Prostate cancer is a leading cause of death among men worldwide, but diagnosing it early remains challenging due to the lack of precise biomarkers. Researchers from Karolinska Institutet, Imperial College London, and Xiyuan Hospital have identified a set of highly accurate biomarkers for prostate cancer using digital tumor models and AI.
The team analyzed thousands of individual cells taken from prostate tumors to build detailed digital models of prostate cancer. They then used artificial intelligence to identify proteins that could serve as biomarkers in urine samples from nearly 2,000 patients.
These new biomarkers outperform the traditional PSA test and offer several advantages, including non-invasive testing, potential at-home diagnosis, and reduced risk of unnecessary biopsies. The researchers believe this breakthrough can lead to earlier detection and better prognoses for men with prostate cancer.
Large-scale clinical trials are planned for the next phase of the research, which will help determine the effectiveness of these new biomarkers in real-world settings.
Source: https://scitechdaily.com/scientists-unveil-breakthrough-urine-test-that-beats-psa-in-spotting-prostate-cancer